| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.31 | 0.09 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |